Libyl Inc.’s Post

📺 The second episode of the LTR Pharma Conversation Series is now live.   101 on Erectile Dysfunction: In this episode, Professor Chung shares insights into Erectile Dysfunction (ED); an explanation of the erectile mechanism; how ED is caused; who it impacts (this one might surprise you); and the potential for SPONTAN® to help those with men’s health issues.   Take a look 👉 https://lnkd.in/gvudm2nf   $LTP #LTRPharma #ASX #menshealth #innovation #pharma #biotech #erectiledysfunction

Discover how life sciences leaders are unlocking operational excellence with smart integration strategies. -If you're in the New England area or willing to fly in, please join this great event for great brainstorming with liked minded individuals! Why you should attend:   - Learn how Blue Mountain RAM's integration with Rainin PipetteX streamlines pipette calibration management by automating certificate transfers and data entry between systems.  - Discover innovative integration strategies that drive ROI.   - Network with peers from leading life sciences organizations.  - Be among the first to explore Blue Mountain RAM's future innovations. #BlueMountain #BlueMountainRAM #R4 #LifeScience #LifeScienceIndustry #GMP #GXP #21CFRPart11 #complianceregulations #CMO #CDMO #CRO #pharma #biotech #meddevice #cellandgene #cmms software #predictivemaintenance #quality #regulatory

I've never met anyone that loves tracking time, but this webinar with Brian Schmidt from Incyte showcases just why you should and the results you can expect with PLW! Check out the insights on how Incyte saved $10M through dynamic resource allocation: https://lnkd.in/g2pa4J5s

Denosumab-bbdz is the first FDA approved interchangeable biosimilar for denosumab (Prolia). Find dosing information, indications, and more in DynaMedex. https://m.ebsco.is/ugGZw #osteopenia #osteoporosis #Prolia

🚨 ICYMI — Yesterday, we partnered with StabilityHub for an insightful webinar on the critical role of performance monitoring and preventative maintenance for stability chambers. During the session, we dove into key takeaways from StabilityHub’s November 2024 article, "A Stability Chamber Problem", and shared real-world examples of how to effectively address unexpected issues that can arise. If you missed it, the full webinar is now available to watch on-demand. Check it out and feel free to share your thoughts or ask any questions in the comments! 👉 Watch the webinar here --> https://lnkd.in/efYVTJWf #ParameterGenerationAndControl #TogetherForABrighterFuture #ParameterHumityControl #TemperatureChamber #StabilityChamber #Pharma #LifeSciences

Did you know that a staggering 90-98% of potential drugs fail between target identification and clinical trials? But here's the exciting news: by integrating cutting-edge QSP technology, workflow, software, and expertise, you can slash that failure rate in half! Hear directly from industry expert John Burke as he highlights the transformative power of scaling biosimulation in our Nasdaq webinar snippet, '𝗗𝗿𝘂𝗴 𝗗𝗲𝘃𝗲𝗹𝗼𝗽𝗺𝗲𝗻𝘁'𝘀 𝗡𝗲𝘄 𝗠𝗼𝗱𝗲𝗹: 𝗕𝗶𝗼𝘀𝗶𝗺𝘂𝗹𝗮𝘁𝗶𝗼𝗻 𝗳𝗿𝗼𝗺 𝗗𝗶𝘀𝗰𝗼𝘃𝗲𝗿𝘆 𝘁𝗼 𝗟𝗮𝗯𝗲𝗹 𝗘𝘅𝗽𝗮𝗻𝘀𝗶𝗼𝗻.' If you're intrigued and eager to learn more about leveraging QSP to accelerate your IND process and unlock critical cost-saving strategies, don't miss out! Watch the full webinar now: https://ow.ly/F37e50Re884

It is with great enthusiasm that we announce the signing of a strategic Memorandum of Understanding (MOU) between Opyl and the Xco consortium, led by Whit Pepper and supported by Dr Greg Bailey. This MOU marks the beginning of a pivotal collaboration, featuring an initial three-month due diligence period to finalise all terms and conditions of the joint venture.   Once established, the joint venture will feature a USD 1 million cash payment, a 20% equity stake, and a lucrative revenue-sharing model. The JV ambitious sales targets are set at USD 1 million in the first year, USD 2 million in the second year, and USD 4 million in the third year. This partnership leverages the vast expertise of our partners and the advanced capabilities of our AI technology to optimise clinical trial design and execution. For investor and marketing enquiries: bernice@trialkey.ai Book a TrialKey demo: https://lnkd.in/grvHkpXN #clinicaldata #medicaladvancements #druginnovation #biotechindustry #medtechsolutions #investmentnews #asxstocks #pharmaresearch #saassolutions

Finding the right solution for intensifying your upstream process is not a one-size-fits-all proposition. Enter your parameters into our app to find the solution that fits your goals. https://lnkd.in/gfPSeX4W #processintensification #biopharma #lifesciences

We are celebrating 5 years of Cirilium Blend with a special investor webinar. Join us on 6 November at 6pm GMT to hear from our portfolio managers, Ian Jensen-Humphreys and Sacha Chorley, on: ✅ Significant achievements and milestones of the Cirilium Blend Portfolios since launch. ✅ What drives these achievements. ✅ Their outlook on markets and how the portfolios are positioned for the future. Save your place 👉 bit.ly/3YiEPh0 The value of investments may go down as well as up and you may not get back the amount originally invested.

If you are a marketing professional in life sciences, you should be connected to SAMPS - Sales And Marketing Professionals in Science. There are not a lot of resources for people in this space and SAMPS is really helping to fill in the gap.